Company / Operating Income
LivaNova Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$199.4M
FY2025
5-year range
-$273.9M / $199.4M
FY2021-FY2025
Trend
+54.5%
vs FY2024
Sector context
#60 of 156
Health Care
What the data says
At $199M, LivaNova's operating income ranks #60 of 156 in the Health Care sector. Operating Income has increased for 3 consecutive years, from -$274M in FY2022 to $199M in FY2025.
Based on SEC 10-K filings.
$199M in FY2025.
Improved from -$68M to $199M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#60 of 156 in Health CareTop 38% of 156This company $199.4M Sector average $733.1M
▼
-72.8% below sector average
Key checks
Key Insights
- LivaNova's operating income has grown for 3 consecutive years.
- In FY2025, operating income increased 54.5% year-over-year.
- Ranks #60 out of 156 companies in the Health Care sector.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $199.4M | +54.5% |
| FY2024 | $129.1M | +288.4% |
| FY2023 | -$68.5M | +75.0% |
| FY2022 | -$273.9M | -59.7% |
| FY2021 | -$171.6M | +37.4% |
| FY2020 | -$273.9M | -59.7% |
| FY2019 | -$171.6M | +30.8% |
| FY2018 | -$248.1M | -357.1% |
| FY2017 | $96.5M | +188.5% |
| FY2016 | $33.4M | +369.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026